[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Investigation Report on China Paroxetine Market, 2010-2019

July 2015 | 35 pages | ID: ICDBA12C177EN
China Research and Intelligence Co., Ltd.

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Description

According to WHO, depression, an affective mental disorder, is quite common with an incidence of 3-5%. Currently, the number of depression patients has exceeded 90 million in China and still keeps increasing. It is expected that by 2020, depression will become the second biggest threat to human health.

As a drug of the selective serotonin reuptake inhibitor (SSRI) type, paroxetine is mainly used for the treatment of depression, obsessive-compulsive disorder and social anxiety and is among one of the three SSRI drugs with certain efficacy (the other two being fluoxetine and paroxetine).

Paroxetine develops fast after entering China despite a slight decline in 2014, annual sales value rising from less than CNY 60 million in 2005 to CNY 204 million in 2013 and CAGR during this period reaching up to 17.3%. Sino-American Tianjin Smith Kline & French Laboratories Ltd, GlaxoSmithKline plc (CA), Beijing Wansheng Pharmaceutical Co., Ltd, Zhejiang Huahai Pharmaceutical Co., Ltd and Zhejiang Jianfeng Pharmaceutical Holdings occupy the majority of the Chinese market, among which Sino-American Tianjin Smith Kline & French Laboratories Ltd had the largest market share of about 69% for sales value in 2014.

With the increased mental pressure brought about by economic development and lifestyle change, the number of depression patients keeps growing too. Therefore, the market size of paroxetine is expected to expand in the next few years in China.

Readers can get at least the following information from this report:
  • market size of paroxetine in China
  • competitive landscape of paroxetine in Chinese market
  • price of paroxetine made by different enterprises in China
  • market outlook of paroxetine in China
The author suggests the following groups of people purchase this report:
  • manufacturers of antidepressant
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service
1 RELATED CONCEPTS OF PAROXETINE

1.1 Indication
1.2 Sales Status in Global Market

2 MARKET PROFILE OF PAROXETINE IN CHINA

2.1 Patent and Approval Status of Paroxetine in China
2.2 Major Manufacturers
2.3 Market Size

3 SURVEY ON SALES STATUS OF PAROXETINE IN CHINA, 2010-2014

3.1 Sales Value
  3.1.1 Overall Sales Value
  3.1.2 Sales Value by Regions
3.2 Sales Volume
  3.2.1 Overall Sales Volume
  3.2.2 Sales Volume by Regions

4 SURVEY O MARKET SHARE OF MAJOR MANUFACTURERS OF PAROXETINE IN CHINA, 2010-2014

4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 SURVEY ON DOSAGE FORMS OF PAROXETINE IN CHINA, 2010-2014

5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 REFERENCE PRICE OF PAROXETINE IN CHINESE HOSPITALS IN 2014

6.1 Sino-American Tianjin Smith Kline & French Laboratories Ltd (Trade Name: Seroxat)
6.2 GlaxoSmithKline plc (Canada) (Trade Name: Seroxat)
6.3 Beijing Wansheng Pharmaceutical Co., Ltd
6.4 Zhejiang Huahai Pharmaceutical Co., Ltd (Trade Name: LEYOU)
6.5 Zhejiang Jianfeng Pharmaceutical Holdings (Trade Name: Shutanluo)

7 MAJOR MANUFACTURERS OF PAROXETINE IN CHINESE MARKET, 2010-2014

7.1 Sino-American Tianjin Smith Kline & French Laboratories Ltd
7.2 Beijing Wansheng Pharmaceutical Co., Ltd
7.3 Zhejiang Huahai Pharmaceutical Co., Ltd
7.4 Zhejiang Jianfeng Pharmaceutical Holdings
7.5 GlaxoSmithKline plc (CA)

8 MARKET OUTLOOK OF PAROXETINE IN CHINA, 2015-2019

8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

TABLE OF SELECTED CHARTS

Chart Patent Status of Paroxetine in China
Chart Approval Information of Paroxetine in China
Chart Sales Status of Paroxetine in China
Chart Sales Value of Paroxetine in China, 2010-2014
Chart Sales Value of Paroxetine in Some Regions in China, 2010-2014
Chart Sales Volume of Paroxetine in China, 2010-2014
Chart Market Share of TOP3 Manufacturers of Paroxetine for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Paroxetine Made by Tianjin SK & F in China, 2010-2014
Chart Sales Value and Market Share of Paroxetine Made by Zhejiang Huahai in China, 2010-2014
Chart Sales Value and Market Share of Paroxetine Made by Zhejiang Jianfeng in China, 2010-2014
Chart Sales Value and Market Share of Paroxetine Made by Other Enterprises in China, 2010-2014
Chart Price of Paroxetine Made by Sino-American Tianjin Smith Kline & French Laboratories Ltd in Some Chinese Cities in 2014
Chart Price of Paroxetine Made by GlaxoSmithKline plc (CA) in Some Chinese Cities in 2014
Chart Price of Paroxetine Made by Beijing Wansheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Paroxetine Made by Zhejiang Huahai Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Paroxetine Made by Zhejiang Jianfeng Pharmaceutical Holdings in Some Chinese Cities in 2014


More Publications